Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

Mackram Eleid; Samuel J Asirvatham; Allison K. Cabalka; Donald J. Hagler; Peter Noseworthy; Nathaniel W. Taggart; Charanjit Rihal

doi:10.1002/ccd.25990

Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

Mackram Eleid, Samuel J Asirvatham, Allison K. Cabalka, Donald J. Hagler, Peter Noseworthy, Nathaniel W. Taggart, Charanjit Rihal

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

Original language	English (US)
Journal	Catheterization and Cardiovascular Interventions
DOIs	https://doi.org/10.1002/ccd.25990
State	Accepted/In press - 2015

Keywords

Percutaneous valve therapy
Structural heart disease intervention
Transcatheter valve implantation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1002/ccd.25990

Cite this

@article{4af9baabaf0840ae87a116c2cfb3948a,

title = "Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads",

abstract = "Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.",

keywords = "Percutaneous valve therapy, Structural heart disease intervention, Transcatheter valve implantation",

author = "Mackram Eleid and Asirvatham, {Samuel J} and Cabalka, {Allison K.} and Hagler, {Donald J.} and Peter Noseworthy and Taggart, {Nathaniel W.} and Charanjit Rihal",

year = "2015",

doi = "10.1002/ccd.25990",

language = "English (US)",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

AU - Eleid, Mackram

AU - Asirvatham, Samuel J

AU - Cabalka, Allison K.

AU - Hagler, Donald J.

AU - Noseworthy, Peter

AU - Taggart, Nathaniel W.

AU - Rihal, Charanjit

PY - 2015

Y1 - 2015

N2 - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

AB - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

KW - Percutaneous valve therapy

KW - Structural heart disease intervention

KW - Transcatheter valve implantation

UR - http://www.scopus.com/inward/record.url?scp=84928957897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928957897&partnerID=8YFLogxK

U2 - 10.1002/ccd.25990

DO - 10.1002/ccd.25990

M3 - Article

C2 - 25946058

AN - SCOPUS:84928957897

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -

Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this